New regulations for pediatric labeling of prescription drugs

被引:9
作者
Nahata, MC [1 ]
机构
[1] CHILDRENS HOSP,WEXNER INST PEDIAT RES,COLUMBUS,OH 43205
关键词
D O I
10.1177/106002809603000921
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:1032 / 1033
页数:2
相关论文
共 6 条
[1]   POPULATION PHARMACOKINETICS OF MIDAZOLAM IN NEONATES [J].
BURTIN, P ;
JACQZAIGRAIN, E ;
GIRARD, P ;
LENCLEN, R ;
MAGNY, JF ;
BETREMIEUX, P ;
TEHIRY, C ;
DESPLANQUES, L ;
MUSSAT, P .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 56 (06) :615-625
[2]  
EDWARDS DJ, 1992, APPLIED PHARMACOKINE, P1
[3]   EFFECT OF AGE ON IBUPROFEN PHARMACOKINETICS AND ANTIPYRETIC RESPONSE [J].
KAUFFMAN, RE ;
NELSON, MV .
JOURNAL OF PEDIATRICS, 1992, 121 (06) :969-973
[4]   NEED FOR CONDUCTING RESEARCH ON MEDICATIONS UNLABELED FOR USE IN PEDIATRIC-PATIENTS [J].
NAHATA, MC .
ANNALS OF PHARMACOTHERAPY, 1994, 28 (09) :1103-1104
[5]  
ROBERTS R, 1996, DRUG INF ASS M GAITH
[6]  
1994, FED REGISTER, V59, P64240